Tivity Health looks to have paid a notable premium for Nutrisystem, but we think shares have been punished a bit too aggressively. While we are not fond of the deal’s price, it makes sense from a strategic standpoint. However, competition in the weight management market will not subside, and integration and execution risk will be key hurdles.
This page is available to subscribers only. To gain access to members only content (including this research piece), click here to subscribe. With a subscription, you'll have access to all of our premium commentary, equity reports, dividend reports and Best Ideas Newsletter and Dividend Growth Newsletter, as well as receive discounts on all of our modeling tools and products. Financial advisers and institutional investors have even more to choose from!